Table 2.
MRSA | Time-to-bed-assignment | Discontinuation Policy |
---|---|---|
Factor (N)a | Minutes Adjustedb |
Adjusted OR (95%CI)c |
PAM with >5 years of experience (N=149/231) | 6.1 | -- |
Large institution (N=88/230) | 7.5 | 1.8 (0.8–3.7) |
Urban setting (N=144/233) | 4.0 | 0.7 (0.3–1.4) |
Cohorting patients permitted (N=60/215) | 12.6* | 2.8 (1.3–6.0)** |
Mixed or double occupancy (N=158/231) | 8.2 | 1.0 (0.5–2.0) |
VRE | Time-to-bed-assignment | Discontinuation Policy |
Minutes Adjustedd |
Adjusted OR (95%CI)e |
|
PAM with >5 years of experience (N=149/231) | 3.7 | -- |
Large institution (N=88/230) | 10.3 | 2.4 (1.2–4.9)* |
Urban setting (N=144/233) | 3.9 | 0.6 (0.3–1.2) |
Cohorting patients permitted (N=60/215) | 9.6 | 1.8 (0.9–3.6) |
Mixed or double occupancy (N=158/231) | 9.3 | 1.3 (0.7–2.6) |
Note. Parameter estimates provided in minutes. MRSA, methicillin-resistant Staphylococcus aureus. VRE, vancomycin-resistant enterococcus. Large institution: >400 beds. Urban setting: >50,000 population.
P<0.05
P<0.01
N=x/y where x is the number of PAMs who reported the characteristic and y is the total number of PAMs who responded to the question.
Sample size for MRSA adjusted model was 176, with 57 responses deleted due to missing values.
Sample size for MRSA adjusted model was 189, with 44 responses deleted due to missing values.
Sample size for VRE adjusted model was 174, with 59 responses deleted due to missing values.
Sample size for VRE adjusted model was 191, with 42 responses deleted due to missing values.